Publication | Open Access

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

MedicineLiver PhysiologyApoptosisPharmacologyBrief ReportPathologyCell DeathSotorasib TherapyHepatotoxicityCancer TreatmentOncologyKrasg12c-mutant Lung CancerLung CancerCancer Research